Innovation Pharmaceuticals (IPIX) Short Interest Ratio & Short Volume → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free IPIX Stock Alerts $0.0025 0.00 (0.00%) (As of 04/24/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest Innovation Pharmaceuticals Short Interest DataCurrent Short Volume18,000 sharesPrevious Short Volume60,900 sharesChange Vs. Previous Month-70.44%Dollar Volume Sold Short$256.50Short Interest Ratio / Days to Cover0.0Last Record DateMarch 31, 2024Today's Trading Volume467,101 sharesAverage Trading Volume753,724 sharesToday's Volume Vs. Average62% Short Selling Innovation Pharmaceuticals ? Sign up to receive the latest short interest report for Innovation Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatIPIX Short Interest Over TimeIPIX Days to Cover Over TimeIPIX Percentage of Float Shorted Over Time Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… Innovation Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/202418,000 shares $256.50 -70.4%N/A0 $0.01 3/15/202460,900 shares $895.23 +1,168.8%N/A0 $0.01 2/29/20244,800 shares $33.60 -93.1%N/A0 $0.01 2/15/202470,000 shares $455.00 No ChangeN/A0.1 $0.01 1/15/2024636,200 shares $6,362.00 +36.5%N/A0.3 $0.01 12/31/2023466,200 shares $2,261.07 No ChangeN/A0.3 $0.00 Get the Latest News and Ratings for IPIX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Innovation Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/15/2023466,200 shares $2,331.00 No ChangeN/A0.6 $0.01 11/30/2023466,200 shares $2,331.00 No ChangeN/A0.4 $0.01 11/15/2023466,200 shares $2,937.06 -2.1%N/A0.6 $0.01 10/31/2023476,200 shares $3,809.60 +2.2%N/A0.9 $0.01 10/15/2023466,200 shares $3,962.70 -7.2%N/A0.3 $0.01 9/30/2023502,600 shares $6,031.20 -8.8%N/A0.7 $0.01 9/15/2023550,900 shares $9,640.75 +7.8%N/A1.1 $0.02 8/31/2023511,100 shares $8,126.49 +9.6%N/A0.5 $0.02 8/15/2023466,200 shares $6,153.84 No ChangeN/A1 $0.01 7/31/2023466,200 shares $7,972.02 No ChangeN/A1.4 $0.02 7/15/2023466,200 shares $8,857.80 -1.8%N/A0.8 $0.02 6/30/2023474,900 shares $9,498.00 +1.9%N/A1.3 $0.02 6/15/2023466,200 shares $8,997.66 -4.3%N/A0.9 $0.02 5/31/2023487,100 shares $8,524.25 +4.5%N/A1.1 $0.02 5/15/2023466,200 shares $8,298.36 No ChangeN/A1.5 $0.02 4/30/2023466,200 shares $8,927.73 No ChangeN/A0.7 $0.02 4/15/2023466,200 shares $7,832.16 -24.9%N/A0.5 $0.02 3/31/2023620,700 shares $12,414.00 +30.3%N/A0.8 $0.02 3/15/2023476,200 shares $8,571.60 -0.6%N/A0.4 $0.02 2/28/2023479,100 shares $7,186.50 +2.8%N/A0.3 $0.02 2/15/2023466,200 shares $8,857.80 No ChangeN/A0.2 $0.02 1/31/2023466,200 shares $9,976.68 No ChangeN/A0.9 $0.02 1/15/2023466,200 shares $11,188.80 -0.1%N/A0.6 $0.02 12/30/2022466,700 shares $8,867.30 -0.6%N/A0.2 $0.02 12/15/2022469,600 shares $9,345.04 +0.7%N/A0.3 $0.02 11/30/2022466,200 shares $10,023.30 No ChangeN/A0.3 $0.02 11/15/2022466,200 shares $10,675.98 No ChangeN/A0.4 $0.02 10/31/2022466,200 shares $13,426.56 -0.3%N/A0.4 $0.03 10/15/2022467,700 shares $14,031.00 +0.3%N/A0.5 $0.03 9/30/2022466,200 shares $15,571.08 No ChangeN/A0.6 $0.03 9/15/2022466,200 shares $18,181.80 No ChangeN/A0.4 $0.04 8/31/2022466,200 shares $18,881.10 No ChangeN/A0.4 $0.04 8/15/2022466,200 shares $22,377.60 -0.7%N/A0.2 $0.05 7/31/2022469,500 shares $18,780.00 -3.5%N/A0.2 $0.04top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… IPIX Short Interest - Frequently Asked Questions What is Innovation Pharmaceuticals' current short interest? Short interest is the volume of Innovation Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 18,000 shares of IPIX short. Learn More on Innovation Pharmaceuticals' current short interest. Is Innovation Pharmaceuticals' short interest increasing or decreasing? Innovation Pharmaceuticals saw a decrease in short interest in March. As of March 31st, there was short interest totaling 18,000 shares, a decrease of 70.4% from the previous total of 60,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Innovation Pharmaceuticals stock? Short selling IPIX is an investing strategy that aims to generate trading profit from Innovation Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Innovation Pharmaceuticals? A short squeeze for Innovation Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IPIX, which in turn drives the price of the stock up even further. How often is Innovation Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IPIX, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: 180 Life Sciences Short Squeeze 3SBio Short Squeeze Abcam Short Squeeze Algernon Pharmaceuticals Short Squeeze Alpha Tau Medical Short Squeeze Apollomics Short Squeeze Artelo Biosciences Short Squeeze Ascentage Pharma Group International Short Squeeze Ascletis Pharma Short Squeeze Avacta Group Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:IPIX) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceFed launches fourth dollar overhaulStansberry ResearchGreat Crypto BullWeiss Ratings